MolNFT v1 · #8130 · protein
Chloramphenicol phosphotransferase in complex with 2-nac-chloramphenicol from streptomyces venezuelae
1GRR · Chloramphenicol 3-O phosphotransferase: “Chloramphenicol phosphotransferase in complex with 2-nac-chloramphenicol from streptomyces venezuelae”. X-ray diffraction, 2 ligands (CLC, SO4), 1 pocket (best druggability 0.67). MolNFT v1…
- PDB
- 1GRR
- Type
- protein
- Length
- 178 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Chloramphenicol 3-O phosphotransferase
- UniProt
- Q56148
- Ligands
- CLC, SO4
- Pockets
- 1 · best druggability 0.67
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Chloramphenicol 3-O phosphotransferase | protein | 178 | 45% helix, 17% strand | Q56148 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 307 | 0.67 | 0.82 | 46 | SO4, CLC |
Compared structures
- 1GRR · CHLORAMPHENICOL PHOSPHOTRANSFERASE IN COMPLEX WITH 2-Nac-CHLORAMPHENICOL FROM… · the same entry in another collection · chain A against A, TM-score 1.00
- Q56148 · AlphaFold monomer V2.0 prediction for chloramphenicol 3-O phosphotransferase (Q56148) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q56148
- Elsewhere: RCSB PDB 1GRR · PDBe 1GRR · UniProt Q56148
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.